News

Allergan, an AbbVie company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of BOTOX to include eight new muscles for the treatment of…
Read More...

Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) has broadened the Emergency Use Authorization (EUA) for baricitinib to allow for treatment with or…
Read More...

Melior Pharmaceuticals (Melior) announced that it completed a definitive licensing agreement with Adhera Therapeutics, Inc . for Melior’s Parkinson’s disease (PD) candidate, MLR-1019…
Read More...

Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced the closing of a $180 million Series C financing round. SoftBank Vision Fund 2* led the financing…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced four new ready-to-use AlphaLISA KRAS kits, designed to help scientists better…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of sotrovimab, an…
Read More...

National Resilience, Inc. (Resilience) and bluebird bio, Inc. announced a strategic alliance aimed to accelerate the early research, development and delivery of cell therapies. As part…
Read More...

Amgen and Teneobio announced an agreement under which Amgen will acquire Teneobio, a privately held, clinical stage biotechnology company developing a new class of biologics called…
Read More...

Dyadic International, Inc. a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate…
Read More...

Lantern Pharma a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug…
Read More...

AbbVie and Calico Life Sciences announced an extension of their leading-edge collaboration to discover, develop and bring to market new therapies for patients with age-related diseases,…
Read More...

Cyclo Therapeutics, Inc. a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with…
Read More...

Biogen. Inc. and Ionis Pharmaceuticals, Inc. announced that topline data from a Phase 1b placebo-controlled, multiple ascending dose clinical study showed that BIIB080/IONIS-MAPTRx met…
Read More...

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases…
Read More...

Nexus Pharmaceuticals announced the launch of Potassium Chloride in Water for Injection in 10mEq/100mL, 10mEq/50mL, and 20mEq/50mL Single-Dose IV bags. “Nexus is proud…
Read More...

GlaxoSmithKline plc announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes…
Read More...

Sun Pharmaceutical Industries Ltd. "Sun Pharma" and includes its subsidiaries and/or associate companies) and Cassiopea SpA, a specialty pharmaceutical company developing and preparing…
Read More...

Alexion’s Ultomiris (ravulizumab) has been recommended for marketing authorisation in the European Union (EU) for expanded use to include children and adolescents with paroxysmal…
Read More...

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced a commercial agreement with Seppic S.A., a supplier of specialty healthcare ingredients,…
Read More...

Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of Canada and the Canadian Institutes of Health Research, published as a pre-print,…
Read More...